Compugen (CGEN) Assets Average (2009 - 2026)
Compugen (CGEN) reported Assets Average of $151.2 million for Q1 2026, up 31.24% on a YoY basis from $115.2 million in Q1 2025, and up 18.87% sequentially from $127.2 million in Q4 2025.
Compugen (CGEN) Assets Average (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Assets Average data on file, last reported at $151.2 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 31.24% year-over-year to $151.2 million; the trailing twelve-month figure through Mar 2026 stood at $151.2 million (up 31.24% YoY), and the FY2025 full-year result was $135.8 million, up 14.91% from the prior year.
- Assets Average improved to $151.2 million in Q1 2026, from $127.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $151.2 million in Q1 2026 to a low of $72.3 million in Q3 2023.
- A 5-year average of $109.0 million and a median of $111.9 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slumped 31.01% in 2023 and surged 61.53% in 2024, its largest moves.
- Tracing CGEN's Assets Average over 5 years: stood at $96.8 million in 2022, then decreased by 2.38% to $94.5 million in 2023, then gained by 26.23% to $119.3 million in 2024, then rose by 6.67% to $127.2 million in 2025, then rose by 18.87% to $151.2 million in 2026.
- Business Quant data shows CGEN's Assets Average at $151.2 million in Q1 2026, $127.2 million in Q4 2025, and $102.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 151.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.22 Mn |
| Dec 31, 2025 | 127.21 Mn |
| Sep 30, 2025 | 102.19 Mn |
| Jun 30, 2025 | 110.98 Mn |
| Mar 31, 2025 | 115.22 Mn |
| Dec 31, 2024 | 119.26 Mn |
| Sep 30, 2024 | 116.84 Mn |
| Jun 30, 2024 | 111.93 Mn |
| Mar 31, 2024 | 117.52 Mn |
| Dec 31, 2023 | 94.47 Mn |
| Sep 30, 2023 | 72.33 Mn |
| Jun 30, 2023 | 80.69 Mn |
| Mar 31, 2023 | 89.25 Mn |
| Dec 31, 2022 | 96.77 Mn |
| Sep 30, 2022 | 104.84 Mn |
| Jun 30, 2022 | 115.62 Mn |
| Mar 31, 2022 | 126.55 Mn |
| Dec 31, 2021 | 126.73 Mn |
| Sep 30, 2021 | 122.06 Mn |
| Jun 30, 2021 | 126.40 Mn |